Etanercept for Tinnitus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests if Etanercept injections can help adults with noise-induced tinnitus by reducing inflammation. The study aims to see if it can lower tinnitus distress and loudness, and improve hearing.
Will I have to stop taking my current medications?
The trial requires a four-week period without any other tinnitus treatments before starting. Some medications, like cyclophosphamide, sulfasalazine, and certain diabetes and immunomodulatory drugs, are not allowed during the study.
Is Etanercept generally safe for humans?
How does the drug Etanercept differ from other treatments for tinnitus?
Etanercept is unique because it is a fusion protein that targets and binds to tumor necrosis factor-alpha (TNF-alpha), a molecule involved in inflammation, which is not a common approach for treating tinnitus. It is typically used for inflammatory conditions like rheumatoid arthritis, and its use for tinnitus is novel, as there are no standard treatments specifically targeting TNF-alpha for this condition.23456
What data supports the effectiveness of the drug Etanercept for treating tinnitus?
Etanercept has been shown to be effective in reducing inflammation in conditions like rheumatoid arthritis and psoriatic arthritis by blocking a protein called TNF-alpha, which is involved in inflammation. While there is no direct evidence for tinnitus, its success in other inflammatory conditions suggests potential benefits.34578
Who Is on the Research Team?
Jinsheng Zhang, Ph.D.
Principal Investigator
Wayne State University
Are You a Good Fit for This Trial?
Adults with moderate to severe tinnitus from noise or blast exposure, or associated with traumatic brain injury (TBI) or concussion. Participants must be stable enough psychologically for the study, not have used other tinnitus treatments in the last four weeks, and able to consent. All hearing levels are included but those with profound loss can't do certain tests.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Etanercept or placebo injections weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment
Exploratory
Exploratory investigations to identify factors influencing therapeutic effects
What Are the Treatments Tested in This Trial?
Interventions
- Etanercept
Etanercept is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
University of Iowa
Collaborator
United States Naval Medical Center, San Diego
Collaborator
University of Miami
Collaborator
Michigan Ear Institute
Collaborator
Madigan Army Medical Center
Collaborator
Portland VA Medical Center
Collaborator